Finance

Lists
MOLN:NASDAQ
Molecular Partners AG
၃.၈၃ US$
-၄.၃၆%
(-၀.၁၇) 1D
ဇူ ၂၈, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MOLN...
Open
၃.၉၂ US$
High
၃.၉၂ US$
Low
၃.၈၃ US$
Mkt. cap
၁၅.၂၆ ကုဋေ
Avg. vol.
၇.၂၉ ထောင်
Volume
၄၃၆.၀၀
52-wk high
၅.၃၆ US$
52-wk low
၃.၄၁ US$
EPS
-၁.၉၁ US$
Beta
၁.၀၁
Shares outstanding
၄.၀၄ ကုဋေ
No. of employees
၁၃၄
Open
၃.၉၂ US$
High
၃.၉၂ US$
Low
၃.၈၃ US$
Mkt. cap
၁၅.၂၆ ကုဋေ
Avg. vol.
၇.၂၉ ထောင်
Volume
၄၃၆.၀၀
52-wk high
၅.၃၆ US$
52-wk low
၃.၄၁ US$
EPS
-၁.၉၁ US$
Beta
၁.၀၁
Shares outstanding
၄.၀၄ ကုဋေ
No. of employees
၁၃၄
News stories
From sources across the web
https://www.dars.gov.et/
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၁ ပတ်
MOLN Q4 2025 Earnings: EPS Beat Highlights Cost Discipline, Stock Slips 4.9% - ROE Trend Analysis
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG
CEO-
Employees၁၃၄
Founded၂၀၀၄
Headquarters-
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to MOLN in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for MOLN in the last 3 months.
Highest
Current ၃.၈၃ US$
၁၃.၀၀ US$ (+၂၃၉.၄၀%)
Average
၁၂.၅၀ US$ (+၂၂၆.၃၅%)
Lowest
၁၂.၀၀ US$ (+၂၁၃.၂၉%)
Analyst
Recommendation
Action
Price target
Projected
Date
Charles Zhu
LifeSci Capital
Buy
Maintained
၁၂.၀၀ US$
+၂၁၃.၃%
07/11/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
၁၃.၀၀ US$
+၂၃၉.၄%
07/06/2026
Jonathan Chang
Leerink Partners
Buy
Reiterated
-
-
06/02/2026
William Maughan
Clear Street
Buy
Maintained
၈.၀၀ US$
+၁၀၈.၉%
03/13/2026
Last report
၂၀၂၆ မေ ၁၂
Fiscal period
Q1 2026
EPS / Est. (CHF)
-၀.၃၅ CHF / -၀.၃၃ CHF
-၆.၀၆%miss
Revenue / Est. (CHF)
- / ၀.၀၀
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
၁.၀၇ ကုဋေ
၈.၃၃ သန်း
၈.၁၈ သန်း
၉.၄၄ သန်း
Cost of revenue
၁.၀၇ ကုဋေ
၈.၃၃ သန်း
၈.၁၈ သန်း
၉.၄၄ သန်း
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၉၉ သန်း
၃.၆၀ သန်း
၄.၄၈ သန်း
၄.၀၀ သန်း
Operating expense
၃.၉၉ သန်း
၃.၆၀ သန်း
၄.၄၈ သန်း
၄.၀၀ သန်း
Total operating expenses
၁.၄၇ ကုဋေ
၁.၁၉ ကုဋေ
၁.၂၇ ကုဋေ
၁.၃၄ ကုဋေ
Operating income
-၁.၄၇ ကုဋေ
-၁.၁၉ ကုဋေ
-၁.၂၇ ကုဋေ
-၁.၃၄ ကုဋေ
Other non operating income
-၃.၀၀ ထောင်
-၂.၀၀ ထောင်
-၅.၀၀ ထောင်
-၄.၀၀ ထောင်
EBT including unusual items
-၂.၀၄ ကုဋေ
-၁.၁၈ ကုဋေ
-၁.၂၆ ကုဋေ
-၁.၃၁ ကုဋေ
EBT excluding unusual items
-၁.၇၈ ကုဋေ
-၁.၁၇ ကုဋေ
-၁.၂၇ ကုဋေ
-၁.၃၁ ကုဋေ
Income tax expense
-
-
၄.၀၀ ထောင်
-
Effective tax rate
-
-
-၀.၀၃%
-
Other operating expenses
-
-
-
-
Net income
-၂.၀၄ ကုဋေ
-၁.၁၈ ကုဋေ
-၁.၂၆ ကုဋေ
-၁.၃၁ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၅၆
-၀.၃၃
-၀.၃၆
-၀.၃၅
Interest and investment income
၄.၂၀ သိန်း
၃.၆၆ သိန်း
၂.၃၄ သိန်း
၁.၇၆ သိန်း
Interest expense
-၄.၀၀ ထောင်
-၃.၀၀ ထောင်
-၆.၀၀ ထောင်
-၇.၀၀ ထောင်
Net interest expenses
၄.၁၆ သိန်း
၃.၆၃ သိန်း
၂.၂၈ သိန်း
၁.၆၉ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၄၁ ကုဋေ
-၁.၁၄ ကုဋေ
-၁.၂၄ ကုဋေ
-၁.၂၉ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more